Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

Companies also provide insights into proposed strategic mergerSAN MATEO, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Vincerx ...

The field of cancer treatment is witnessing rapid advancements due to progress in proteomics, genomics, and drug discovery. These technologies have ...

With such volatility, SLXN has emerged as one of the most talked-about stocks of the day, creating a buzz in the biotechnology sector. Let’s dive into the details behind this remarkable movement and ...

Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could significantly improve the effectiveness of peptide-based cancer vaccines, ...

Seattle doctors developed a blood test that determines the parental origin of the RB1 mutation in retinoblastoma.

Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...

Triple-negative breast cancer (TNBC) has long been one of the most difficult forms of breast cancer to treat. Unlike other breast cancer subtypes, TNBC lacks ...

The company is in the midst of a rebranding initiative, which will soon reflect its name change to IMAC Holdings, Inc., doing business as Ignite Sciences, Inc. This transition signals its sharpened ...

A pioneering study has unveiled the Au-HN-1 nanosystem, a cutting-edge approach that promises to transform the diagnosis and ...

Trial of Cell-Based Therapy for High-Risk Lymphoma Leads to FDA Breakthrough Designation ... 2024 — A new detailed analysis of a patient's second cancer after receiving CAR-T therapy for the ...

A pioneering study has unveiled the Au-HN-1 nanosystem, a cutting-edge approach that promises to transform the diagnosis and ...